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There is increasing evidence that CD8 lymphocytes may represent targets for infection by human immuno-
deficiency virus type 1 (HIV-1) in vivo whose destruction may contribute to the loss of immune function
underlying AIDS. HIV-1 may infect thymic precursor cells destined to become CD4 and CD8 lymphocytes and
contribute to the numerical decline in both subsets on disease progression. There is also evidence for the
induction of CD4 expression and susceptibility to infection by HIV-1 of CD8 lymphocytes activated in vitro. To
investigate the relationship between CD8 activation and infection by HIV-1 in vivo, activated subsets of CD8
lymphocytes in peripheral blood mononuclear cells (PBMCs) of HIV-seropositive individuals were investigated
for CD4 expression and HIV infection. Activated CD8 lymphocytes were identified by expression of CD69,
CD71, and the human leukocyte antigen (HLA) class II, the -chain of CD8, and the RO isoform of CD45.
CD4 and CD4 CD8 lymphocytes, CD4 lymphocytes, other T cells, and non-T cells were purified using
paramagnetic beads, and proviral sequences were quantified by PCR using primers from the long terminal
repeat region. Frequencies of activated CD8 lymphocytes were higher in HIV-infected study subjects than in
seronegative controls, and they frequently coexpressed CD4 (mean frequencies on CD69, CD71, and HLA
class II cells of 23, 37, and 8%, respectively, compared with 1 to 2% for nonactivated CD8 lymphocytes). The
level of CD4 expression of the double-positive population approached that of mature CD4 lymphocytes. That
CD4 expression renders CD8 cell susceptible to infection was indicated by their high frequency of infection in
vivo; infected CD4 CD8 lymphocytes accounted for between 3 and 72% of the total proviral load in PBMCs
from five of the eight study subjects investigated, despite these cells representing a small component of the
PBMC population (<3%). Combined, these findings provide evidence that antigenic stimulation of CD8
lymphocytes in vivo induces CD4 expression that renders them susceptible to HIV infection and destruction.
The specific targeting of responding CD8 lymphocytes may provide a functional explanation for the previously
observed impairment of cytotoxic T-lymphocyte (CTL) function disproportionate to their numerical decline in
AIDS and for the deletion of specific clones of CTLs responding to HIV antigens.
Infection with human immunodeficiency virus type 1
(HIV-1) is associated with progressive destruction of CD4
T-helper lymphocytes and the development of the profound
immunodeficiency that underlies AIDS. The targeting of CD4
lymphocytes by HIV-1 is thought to result from expression of
cell surface CD4 (11, 26, 31), the chemokine receptor CXCR4
(15), and (on activation) CCR5 (1, 13), which act as receptors
for the attachment and entry of HIV-1. CD4 and CCR5 ex-
pression probably also accounts for the infection of macro-
phages and macrophage-derived cell types in vivo, although the
effect that this has on the immune system is unresolved.
Whether HIV-1 targets other cells in the immune system
and whether infection and direct or indirect destruction of
CD4 lymphocytes entirely accounts for the immunodeficiency
observed in AIDS have remained controversial. It is possible
that HIV-1 may be able to infect other lymphoid cells through
a CD4-independent mechanism (as has been suggested for the
infection of astrocytes in the central nervous system), or it may
target cells that transiently express CD4 during maturation or
activation. Many investigators have provided evidence for the
widespread infection in vitro and in vivo of human CD8,
cytotoxic T lymphocytes by HIV-1 (16, 30, 32, 34, 50, 54) or by
the primate simian immunodeficiency virus (SIV) homologues
SIVmac in sooty mangabeys (12) and SIVagm in African green
monkeys (37). Infection of cells destined to become CD8 lym-
phocytes may occur through a conventional CD4-dependent
mechanism during their maturation in the thymus, at the stage
where CD4 is coexpressed with CD8 (12, 24). Destruction of
thymic precursor cells may significantly deplete the pool of
both CD4 and CD8 lymphocytes; infection at this stage may
subsequently be manifested by the appearance of a population
of HIV provirus-positive, antigen-naive CD8 lymphocytes in
the peripheral circulation comprising cells that survived infec-
tion. This hypothesis is supported by the finding that implants
of human thymic tissue containing HIV-1-infected double-
positive (DP) thymocytes was followed by the appearance of
infected single-positive CD8 lymphocytes in the peripheral cir-
culation (9, 24, 28). The hypothesis of thymic infection is fur-
ther supported by our recent observation of the distribution of
proviral sequences in CD8 lymphocytes expressing the RA
(naive) isoform of CD45 (32).
Very recently, isolation of HIV-1 from purified CD8 lym-
phocytes from two AIDS patients was described, which produced
apparently CD8-tropic variants that could be propagated in
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transformed CD8 lymphocyte cultures or mitogen-stimulated
cultures of peripheral blood mononuclear cells (PBMCs) (44).
Their subsequent biological characterization led to the propo-
sal that these variants infect CD8 lymphocytes through initial
attachment to CD8 instead of CD4 (54). These isolates showed
the additional peculiarity of not using CCR5, CXCR4, or other
known coreceptors in mediating subsequent virus entry steps.
Apart from intrathymic and CD8-independent mechanisms
for infection of CD8 lymphocytes, several investigators have
demonstrated that in vitro activation of purified peripheral
CD8 lymphocytes with mitogens, anti-CD3 and anti-CD28 an-
tibodies, or antigen-pulsed autologous dendritic cells leads to
de novo synthesis of CD4 expression, sufficient to confer sus-
ceptibility to infection with laboratory isolates of HIV-1 (16,
23, 50). However, it is presently unknown whether up-regula-
tion or de novo synthesis of CD4 on CD8 lymphocytes also
occurs in vivo. To investigate this issue and the possibility that
CD4 expression on CD8 lymphocytes confers susceptibility to
HIV infection in vivo, we have measured the expression of
CD4 on activated and nonactivated CD8 lymphocytes recov-
ered from peripheral blood of HIV-infected and uninfected
individuals. In addition, the distribution of HIV-1 sequences in
isolated cell subsets, in particular in relation to expression of
CD4 on CD8 lymphocytes from eight HIV-seropositive patient
PBMC samples, was assessed.
MATERIALS AND METHODS
Samples and clinical details of study subjects. Volumes of 20 to 30 ml of
whole blood anticoagulated with EDTA were obtained by venipuncture from 5
HIV-seronegative controls (S1 to S5) (3 male and 2 female; mean age, 27.6 years
[range, 23 to 40 years]) and from 20 HIV-seropositive individuals attending the
Regional Infectious Diseases Unit, Western General Hospital, Edinburgh,
United Kingdom. Information on CD4 count, viral load, duration of therapy, and
risk group for the HIV-seropositive individuals is presented in Table 1. HIV
plasma virus levels were determined by a commercially available PCR assay
(Roche Monitor, Lewes, East Sussex, United Kingdom).
Immunomagnetic T-cell separation. PBMCs were obtained from whole blood
by density centrifugation over Lymphoprep separation medium (Nycomed
Pharma AS). T lymphocytes were purified from the isolated PBMCs by negative
selection using the pan-T-cell kit (Miltenyl Biotec) on an AutoMACS system,
with all solutions kept on ice to help prevent capping and patching of antibodies
on the surface of the cells and retard any possible cellular activation that was
occurring. Analysis of the levels of activation of CD69 on T lymphocytes before
and after immunomagnetic separations did not show any evidence for cellular
activation occurring during the purification process (mean percent expression [n 
3]: prepurification CD4 CD69, 0.18%; prepurification CD8 CD69, 0.54%;
postpurification CD4 CD69, 0.21%; postpurification CD8 CD69, 0.43%).
For quantification of HIV-1 proviral levels in different cell subsets, T lympho-
cytes were isolated as described above and the cells remaining in the column
were eluted and are referred to as non-T cells, which would consist of B lympho-
cytes, dendritic cells, monocytes, and NK cells. Contaminating -T-cell receptor
(-TCR)-expressing lymphocytes were removed using the  microbead kit
(Miltenyl Biotec). From the remaining -TCR T lymphocyte fraction, CD8
and CD8 lymphocytes were isolated by positive selection using the CD8 mul-
tisort kit (Miltenyl Biotec). From the CD8 fraction, the CD8 microbeads were
enzymatically removed from the selected fraction according to the manufactur-
er’s instructions. The CD8 lymphocyte fraction was then further separated by
positive selection using CD4 microbeads (Miltenyl Biotec) to give CD8 CD4
and CD8 CD4 lymphocyte fractions. From the CD8 fraction, CD4 lympho-
cytes were isolated by positive selection for CD4 using CD4 microbeads (Miltenyl
Biotec) to give CD4 CD8 and CD4 CD8 lymphocyte fractions. For the pur-
pose of this study, the non--TCR-expressing lymphocytes and those lympho-
cytes which were CD4 CD8 were combined and are referred to as other T cells.
Flow cytometric analysis. Flow cytometric analysis was carried out on an
FACSCalibur flow cytometer (Becton Dickinson, Crawley, United Kingdom) by
gating on lymphocytes based on their forward and side scatter parameters, with
a minimum of 10,000 events collected. For analysis of CD4 expression on CD8
lymphocytes, further gates were placed around those CD8 T cells based on the
expression of activation markers and the level of CD4 expression was plotted.
Monoclonal antibodies and isotype-matched mouse immunoglobulin controls
(labeled with phycoerythrin [PE], PE-Cy5 [Cy5], and fluorescein isothiocyanate
isomer 1 [FITC]) to the following cell surface markers were obtained: CD3-PE
(clone UCHT1), CD4-Cy5 (clone MT310), CD8-FITC (clone DK25), CD14-PE
(clone TUK4), CD45-FITC (clone T29/33), and pan-HLA class II–FITC (clone
CR3/43) (Dako, Ely, United Kingdom); CD69-FITC (clone FN50) and CD71-
FITC (clone M-A712) (BD Pharminigen, Crowley, United Kingdom); and CD8
-chain–PE (clone 2ST8.5H7) (Coulter Immunotech, High Wycombe, Bucking-
hamshire, United Kingdom).
Detection and quantitation of HIV sequences. DNA was extracted from se-
lected cell subsets using the QIAamp DNA Mini kit (Qiagen Ltd., Crawley,
United Kingdom). HIV proviral sequences were quantified by limiting-dilution
nested PCR using a nested set of highly conserved PCR primers from the
complete long terminal repeat (LTR) region. Pan-LTR primers were 5-GRAA
CCCACTGCTTAASSCTCAA-3 (outer, sense), 5-TGTTCGGGCGCCACTG
CTAGAGA-3 (outer, antisense), 5-CTCAATAAAGCTTGCCTTGAG-3 (in-
ner, sense), and 5-GAGGGATCTCTAGNYAVVAGAGT-3 (inner, antisense)
(5 base positions 506, 626, 524, and 578 in the HXB2 genome, respectively).
Complete LTR (C-LTR) primers were 5-ACTCTGGTRNCTAGAGATCCC
TC-3 (outer, sense), 5-GGCGTACTCACCAGTCGCCG-3 (outer, anti-
sense), 5-TCTCTAGCAGTGGCGCCCGAAC-3 (inner, sense), and 5-TCAG
CAAGCCGAGTCCTG-3 (inner, antisense) (5 base positions 578, 735, 626,
and 692 in the HXB2 genome, respectively). The binding sites of the pan-LTR
and C-LTR primers in the HIV-1 genome were chosen to allow detection of all
cDNA transcripts and of completed proviral sequences, respectively (Fig. 1).
Both primary and secondary reactions for pan-LTR and C-LTR primers were
carried out using the following parameters: 94°C for 18 s, 55°C for 21 s, and 72°C
for 1 min 30 s for 30 cycles followed by a final extension step of 72°C for 6 min.
PCR amplicons were run at 150 V for 30 min on 2% (wt/vol) agarose gels
containing 0.5 	g of ethidium bromide/ml and visualized under UV light. Quan-
tification of the proviral load in each of the selected cell subsets was performed
by limiting-dilution PCR as previously described (45).
RESULTS
Purity of immunomagnetically isolated T lymphocytes. T
lymphocytes were separated from PBMCs by negative selec-
tion by incubation with a cocktail of immunomagnetically la-
beled antibodies to B-lymphocyte, dendritic cell, monocyte,
and NK cell markers. Labeled cells were then passed through
TABLE 1. Clinical profile of HIV-seropositive study subjects,













p1 F 41 IVDU 25 109,000 NTc
p2 M 53 IVDU 35 83,100 24
p3 F 34 WSM 87 
750,000 2
p4 M 44 IVDU 94 205,000 6
p5 F 40 IVDU 104 14,800 NT
p6 F 39 WSM 117 50 17
p7 F 37 WSM 201 2,100 NT
p8 F 43 WSM 207 105,000 12
p9 F 38 WSM 236 101 14
p10 M 37 MSM 252 1,030 3
p11 M 48 MSM 325 50 31
p12 F 35 IVDU 334 139,000 NT
p13 M 64 Needlestick 334 400 7
p14 F 33 WSM 399 50 25
p15 F 25 WSM 420 50 11
p16 M 37 MSM 430 20,500 NT
p17 M 38 MSM 536 924 1
p18 F 41 WSM 546 50 33
p19 M 44 IVDU 713 41,400 NT
p20 M 41 IVDU 826 50 12
a M, male; F, female.
b IVDU, intravenous-drug abuser; MSM, man who has sex with men; WSM,
woman who has sex with men; needlestick, needlestick injury.
c NT, no therapy given.
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a separation column held in a magnetic field, with phenotypi-
cally unchanged T lymphocytes passing straight through. Be-
tween 1.3 and 9.8 million T lymphocytes were isolated from
PBMCs of the uninfected and HIV-infected study subjects, of
which at least 94.4% (HIV-negative subjects) to 96.1% (HIV-
positive subjects) of the total sorted T cells expressed CD3 and
CD45 (Table 2). The proportions of cells recovered that ex-
pressed CD4 were approximately the same numbers when
compared to previously determined CD4 absolute counts
(Table 1). The frequency of monocyte (CD45 CD14) con-
tamination was less than 2%. Isolated T lymphocytes were
subsequently further purified by immunomagnetic isolations to
obtain CD4-expressing CD8 lymphocytes and other relevant
T-cell subsets.
Activation markers on CD4 and CD8 lymphocytes. Expres-
sion of the cell surface markers CD69, CD71, and HLA class II
was used to identify activated CD4 and CD8 lymphocytes (Fig.
2). HIV-positive study subjects showed higher frequencies of
activated CD8 lymphocytes (mean values [range] of 1.2% [0.4
to 2.4%], 1.3% [0.4 to 1.9%], and 17.5% [2.4 to 37.9%] for the
three markers, respectively) than the HIV-negative controls
(0.28% [0.2 to 0.3%], 0.42% [0.1 to 1.6%], and 2.7% [0.8 to
7.4%], respectively). Frequencies of activated CD4 lympho-
cytes were comparable between the two study groups (CD69,
1.0% [HIV positive] compared with 1.2% [HIV negative];
CD71, 4.7% [HIV positive] and 4.2% [HIV negative]; and
HLA class II, 4.7% [HIV positive] and 4.2% [HIV negative]).
CD4 expression on activated and nonactivated CD8 lympho-
cytes. Expression of CD4 on activated and nonactivated CD8
lymphocytes was determined by three-color flow cytometry
(Fig. 3). CD4 expression was more frequent on activated cells,
irrespective of the activation marker used and the HIV status
of the study subject. For example, 21.6% (mean for HIV-
negative subjects) and 23.6% (mean for HIV-positive subjects)
of the CD69 CD8 lymphocyte population expressed CD4,
compared with 2.1 and 1.7%, respectively, in CD69 CD8
lymphocytes. An even greater (20-fold) difference in frequency
of CD4 expression was observed between CD71 and CD71
cells in both study groups. The proportion of CD8 lymphocytes
expressing CD4 varied between the activation markers, with
lower frequencies of CD4 expression observed on the HLA
class II lymphocytes.
To investigate whether DP lymphocytes were CD4 lympho-
cytes with aberrant CD8 -homodimer expression (8, 20, 21,
39), the presence of CD8 -heterodimers (found on true CD8
lymphocytes) was detected by flow cytometry for CD8 -chain-
and -chain-specific antibody (Table 3). Although the individ-
ual measurements were subject to stochastic sampling errors,
there was no evidence for an excess of CD4 expression on CD8
-chain-positive lymphocytes over that found on lymphocytes
expressing the CD8 -chain (n  7; mean values of 2.76%
[-chain] and 2.77% [-chain]). These results indicate that
CD8 -chain-expressing lymphocytes are capable of expressing
CD4 and exclude the possibility that CD4 lymphocytes were
expressing the CD8  homodimer.
To further confirm that our results were due to CD4 expres-
sion on true CD8 lymphocytes, CD4 and CD71 expression on
CD8 -chain-expressing lymphocytes was analyzed and com-
pared with the expression of CD4 on CD4 lymphocytes. The
amount of CD4 expressed on the CD4 fraction of CD71
(activated) CD8 -chain-expressing lymphocytes was similar
to that on CD4 lymphocytes (Fig. 4) (geometric mean fluores-
cence intensity [GMFI] of CD4 expression on CD8 CD71 
360.85; GMFI on CD3 CD4  506.14). CD4 expression on
activated CD8 lymphocytes identified by other activation
markers (CD69 and HLA class II) was similar to that observed
on the CD71 cells; levels of CD4 expression were also com-
parable between activated CD8 lymphocytes from HIV-sero-
positive and -seronegative individuals (data not shown).
CD45 isoform expression on CD4 CD8 lymphocytes. To
determine whether expression of CD4 on CD8 -chain-ex-
pressing lymphocytes occurred on immature thymocytes re-
cently released into the periphery from the thymus or on ac-
tivated mature lymphocytes, we compared expression of naive
(CD45RA) and memory (CD45RO) cell markers on CD4-ex-
pressing CD8 lymphocytes. Immature thymocytes are antigen
inexperienced and therefore exclusively express the CD45RA
isoform. In contrast, mature lymphocytes responding to anti-
gen would up-regulate the CD45RO isoform. By flow cytom-
etry using antibodies to CD45RA, CD45RO, and CD4, we
found that CD8 lymphocytes in all samples examined ex-
TABLE 2. Purity of isolated T lymphocytes from PBMC samples
obtained from HIV-seronegative and -seropositive individualsa
Study subject
% of lymphocytes:
CD14 CD45 CD3 CD45 CD3 CD4 CD3 CD8
Seronegative
S1 0.1 96.4 53.4 43.6
S2 0.1 95.4 65.1 30.5
S3 1.8 96.5 62.2 33.8
S4 0.1 94.4 69.4 26.1
S5 1.9 96.2 40.7 53.3
Mean 0.8 95.8 58.2 37.5
Seropositive
p4 0.2 96.1 16.7 76.8
p6 0.8 97.1 13.3 74.6
p11 0.9 97.5 35.6 66.8
p15 0.2 99.1 63.1 36.6
p17 0.4 99.4 51.5 47.8
Mean 0.5 97.8 36.1 60.5
a HIV-seropositive individuals were ranked from low to high CD4 count. A
minimum of 10,000 events were collected for each analysis.
FIG. 1. Binding sites of the pan-LTR and C-LTR primers used for
detection of proviral LTR sequences. Numbers in parentheses indicate
the 5 base positions in the HXB2 genome. Abbreviations: PBS, prim-
er binding site; OS, outer, sense; IS, inner, sense; IAS, inner, antisense;
OAS, outer, antisense.
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pressed high levels of CD45RO in conjunction with CD45RA
(Fig. 5) (n  7; mean percent CD45RO  61.50% [range,
42.99 to 81.82%], mean percent CD45RA  26.02% [range,
8.16 to 58.50%]). The expression of CD45RO rules out the
possibility that the CD4-expressing CD8 lymphocytes are im-
mature thymocytes.
Detection of HIV proviral sequences in isolated cell subsets.
T lymphocytes were isolated from PBMC samples by immu-
nomagnetic negative selection, and CD4 and CD8 lymphocytes
were separated from T-lymphocyte samples by positive selec-
tion for CD4 and CD8, respectively. The isolation procedure
for CD8 lymphocytes produced less than 0.5% contamination
with CD4 lymphocytes (n  7; range, 0.3 to 0.5%). This al-
lowed the calculation of the proviral load found in the CD8
lymphocyte fractions due to “worst-case” CD4 contamination
(see below). Further immunomagnetic separations on the CD8
FIG. 2. Expression of the activation markers CD69 (A), CD71 (B), and HLA class II (C) on CD4 and CD8 lymphocytes from HIV-seronegative
(S1 to S5) and HIV-seropositive (p4 to p17) individuals. HIV-seropositive individuals were ranked from low CD4 count (p4) to high CD4 count
(p17); mean values for expression of each activation marker on CD4 and CD8 lymphocytes in the seronegative and seropositive groups are
indicated above the histograms. A minimum of 7,500 lymphocytes from each individual were collected and analyzed.
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lymphocytes based on the expression of CD4 were carried out
to give the CD8 CD4 and CD8 CD4 fractions. HIV
proviral sequences were detected using two sets of highly con-
served primers directed against the LTR region that allowed
detection of incomplete and complete HIV transcripts, as pre-
viously described (32). Proviral loads in CD4, CD4 CD8, and
CD4 CD8 lymphocytes using the two sets of primers were
comparable, with no evidence for a significant excess of se-
quences detected by the pan-LTR primers when six HIV-
seropositive samples were analyzed (Fig. 6) (Spearman cor-
relation coefficient [r]  0.724; P  0.001). Using the C-LTR
primers and assuming the worst-case scenario for CD4 lym-
phocyte contamination of the isolated CD8 lymphocyte frac-
tions, 3.1% of the detected proviral load could be attributed
FIG. 3. Comparison of frequencies of CD4 expression on activated and nonactivated CD8 lymphocytes identified by CD69 (A), CD71 (B), and
HLA class II (C) from HIV-seronegative (S1 to S5) and HIV-seropositive (p4 to p17) individuals. Mean values for CD4 expression on each
activated and nonactivated lymphocyte subset are indicated above the histograms. A minimum of 7,500 lymphocytes from each individual were
collected and analyzed.
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to CD4 lymphocyte contamination in the CD4 CD8 lympho-
cyte fractions (for samples p2, p7, p9, p14, and p20) and in the
CD4 CD8 fractions (samples p2 and p8). CD4 lymphocyte
contamination was greater than 10% in the remaining two
samples (p19, 32% in the CD4 CD8 lymphocyte fraction; p3,
12% in the CD4 CD8 fraction), and these were omitted from
subsequent analysis.
Contribution of individual cell subsets to total proviral load.
HIV sequences in DNA samples from each of the purified cell
subsets from eight HIV-seropositive individuals were quanti-
fied using C-LTR primers, and the contribution of each subset
to the total proviral load detected in PBMCs was calculated
(Fig. 7). LTR sequences could be detected in all samples of
CD4 lymphocytes and contributed 22 to 69% of the total
PBMC proviral load. Proviral sequences were detected in five
of eight samples of CD4 CD8 lymphocytes and at lower
frequencies in two of eight samples of CD4 CD8 lympho-
cytes. The contribution of CD8 lymphocyte infection to overall
proviral load in PBMCs varied considerably between individ-
uals; in two cases, the majority of the infected PBMCs com-
prised CD4 CD8 lymphocytes (p9 and p14). There was no
association between CD4 or CD4 CD8 lymphocyte infec-
tion and CD4 count. Frequencies of HIV infection in the
different PBMC subsets did not correlate with disease status,
risk group, or antiviral therapy (Table 1).
DISCUSSION
CD4 expression on activated CD8 lymphocytes. This study is
the first to demonstrate high frequencies of CD4 expression on
the activated subset of CD8 lymphocytes in vivo. This was
achieved by comparison of frequencies of CD4 expression on
CD8 lymphocytes colabeled with the activation markers CD69,
CD71, and HLA class II, as well as the different isoforms of
CD45. CD4 expression was detected on approximately 20 to
40% of CD8 lymphocytes identified as activated by expression
of CD69 or CD71 and on a significant proportion of the much
large number of HLA class II-positive cells (Fig. 3). Quantita-
tive analysis of CD4 expression on DP lymphocytes indicated a
level of CD4 expression comparable to that of CD4 lympho-
cytes (GMFI values of 360 and 500, respectively [Fig. 4]).
TABLE 3. Comparison of the percent expression of CD4 on
CD8 or CD8 lymphocytes from seven HIV-seropositive
individuals, ranked from low to high CD4 counta
Study subject
% of lymphocytes expressing CD4









a A minimum of 25,000 -TCR lymphocytes from each individual sample
were analyzed.
FIG. 4. Flow cytometric analysis of CD4 expression on activated and nonactivated CD8 lymphocytes. (A) Forward and side scatter plots of
immunomagnetically isolated T lymphocytes (purity of T cell isolation: CD3 -TCR, 94.69%; CD3 -TCR, 2.18%). (B) Dual-parameter
plot of CD8 and CD71 expression from the R1 gate highlighting the activated CD8 lymphocytes (CD71, R2 gate) and nonactivated CD8
lymphocytes (CD71, R3 gate). (C) Histogram of CD4 expression from CD71 CD8 lymphocytes (R3 gate). (D) Histogram of CD4 expression
from CD8 lymphocytes from panel B. (E) Histogram of CD4 expression from CD71 CD8 lymphocytes (R2 gate). The frequency of CD4-
expressing cells is shown in the histograms; the GMFI of CD4 expression in CD4 populations is indicated below this frequency. Open histograms
refer to the binding of an isotype-matched control antibody. A minimum of 25,000 CD8 lymphocytes from each individual were collected and
analyzed.
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These levels of expression were greater than those observed on
CD8 lymphocytes activated in vitro through mitogens, anti-
CD3/anti-CD28, or, more recently, pulsing of CD8 lympho-
cytes with antigen-bearing dendritic cells (16, 23, 50). It is
possible that the greater CD4 expression detected in vivo in
this study may result from differences in the cellular milieu in
which CD8 activation takes place and/or differences between
antigenic and nonphysiological methods for T-cell stimulation.
To exclude the possibility that the DP lymphocytes identified
represented aberrant CD8 -chain expression on CD4 lympho-
cytes (8, 20, 36, 39), we demonstrated approximately equal
frequencies of CD4 expression on lymphocytes expressing the
- and -chains of CD8, demonstrating that CD4 expression
was confined to true CD8 lymphocytes (20). Similarly, al-
though CD69 is expressed on recent thymic emigrants (49),
they differ from CD8 lymphocytes activated by antigenic stim-
ulation by the absence of the expression of the RO isoform of
CD45 (47). High-level expression of CD45RO on the DP lym-
phocytes examined in this study provided clear evidence that
they represented activated lymphocytes rather than recent thy-
mic emigrants. The levels of CD45RA and CD45RO found on
DP lymphocytes in vivo was similar to that found in in vitro
studies (16), with dual expression of CD45RA and CD45RO
previously associated with cellular activation (27).
Taken together, these findings indicate that de novo CD4
expression is a component of the phenotypic change that oc-
curs in CD8 lymphocytes on cellular activation and is one
that may play a functional role in subsequent cellular interac-
tions. In the future, culture systems that more fully replicate
the physiological conditions of CD8 activation in vivo may
provide information on the functional significance of CD4 up-
regulation. This issue is particularly relevant for HIV-infected
individuals, in whom increased frequencies of activated lym-
phocytes, particularly cytotoxic T cells, accompany infection
and disease progression (Fig. 2) (2–4, 6,7, 17, 19, 41).
Susceptibility of CD8 lymphocytes to HIV infection. This
study documents the specific association of HIV infection with
the activated subset of CD8 lymphocytes in vivo. Although DP
CD8 lymphocytes numerically represent a minor subset of CD8
lymphocytes (accounting for only 0.25 to 7% of CD8 lympho-
cytes found in peripheral blood) (Table 3), greater proviral
loads were found in this subset compared with CD4 CD8
lymphocytes in six of the eight study subjects (Fig. 7). It is possible
that the HIV-infected CD4 CD8 lymphocytes detected in this
study correspond to the infected CD45RA CD8 lymphocytes
FIG. 6. Correlation between proviral loads in different lymphocyte
subsets measured by the C-LTR primers (x axis) and the pan-LTR
primers (y axis); the regression line and Spearman’s correlation coef-
ficient are shown. Symbols: E, CD4 lymphocyte; F, CD4 CD8 lym-
phocyte; , other T cell; }, non-T cell.
FIG. 5. Analysis of the levels of expression of CD45RA (naive) and CD45RO (memory) cell markers on CD8 -chain-positive lymphocytes
expressing CD4 molecules. A minimum of 15,000 CD8 lymphocytes from each individual were collected and analyzed.
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reported in our previous study (32). Those cells had been
initially purified using negative selection for CD8, a procedure
which would have removed the CD8 DP population analyzed
in the present study. It is therefore possible that two popula-
tions of HIV-infected CD8 lymphocytes may be present in the
peripheral circulation, one associated with naive CD8 lympho-
cytes infected previously in the thymus and one associated with
activated, DP CD8 lymphocytes after antigenic exposure.
In common with our previous work on CD8 lymphocyte
infection (30, 32), we acknowledge that while magnetic bead
separation can produce highly purified subsets of lymphocytes
suitable for PCR-based detection of HIV proviral sequences,
considerable care has to be taken to ensure that the proviral
sequences detected in CD8 lymphocytes did not originate from
low frequencies of contaminating CD4 lymphocytes or other cell
types. As with the previous study (32), a combination of purity
measurements with calculations of the worst-case contribution to
proviral load of contaminating CD4 lymphocytes indicated that
proviral sequences detected in at least seven of the nine im-
munomagnetically purified subsets of CD8 lymphocytes could
not have originated from contaminating CD4 cells. Similarly,
the purity of T cells isolated by the pan-T negative selection
method and the lack of significant monocyte contamination
(Table 2) provided evidence against a significant contribution
to proviral load by other cell types in the PBMC population.
The expression of high levels of CD4 of activated CD8
lymphocytes detected in this study potentially confers a phe-
notype susceptible to infection with HIV. Productive infection
would be further favored by the activation status of the CD8
lymphocytes, which provides a suitable internal cellular envi-
ronment for completion of reverse transcription, integration,
and viral gene expression (10, 14, 43, 46, 48, 51, 52), as well as
up-regulating expression of the chemokine receptor, CCR5
(23), whose expression is required for entry of the majority of
HIV variants in vivo (5, 35).
Apart from our direct evidence for extensive infection of DP
CD8 lymphocytes in vivo, the hypothesis that activated CD8
lymphocytes may be susceptible to HIV infection is further
supported by observations of productive infection of mitogen-
or anti-CD3, anti-CD28-stimulated CD8 lymphocytes in vitro
in a CD4-dependent manner (16, 23, 50). Furthermore, this in
vitro susceptibility was observed despite the induction of gen-
erally lower levels of CD4 expression than observed on acti-
vated CD8 lymphocytes in vivo (see above). A direct cytopathic
effect of HIV on CD8 lymphocytes as they become activated
may therefore contribute to the decline in numbers and the
even more marked functional impairment of CD8 lymphocytes
observed upon disease progression.
Clinical significance of CD8 lymphocyte infection. Whether
direct infection of CD8 lymphocytes contributes to the immu-
nodeficiency observed in AIDS remains to be demonstrated,
and there are a number of other mechanisms for the observed
numerical decline and functional impairment of CD8 lympho-
cytes observed on disease progression. These include indirect
FIG. 7. Contribution to overall proviral load of CD4 lymphocytes, CD4 and CD4 CD8 lymphocytes, other T cells, and non-T cells (expressed
as copies per 106 PBMCs) in peripheral blood samples from eight HIV-seropositive individuals. HIV-seropositive individuals were ranked from
low CD4 count (p2) to high CD4 count (p20). VL, circulating viral load (RNA copies per milliliter of plasma).
11562 IMLACH ET AL. J. VIROL.
mechanisms such as the loss of CD4 lymphocyte helper func-
tion leading to impaired clonal expansion and function of CD8
lymphocytes on antigenic exposure (22). CD8 lymphocytes may
also become more susceptible to apoptosis from alterations in
the cytokine milieu in lymphoid tissue, bystander effects from
neighboring productively infected CD4 lymphocytes, or toxic-
ity from the release of HIV-encoded proteins such as gp120 or
Tat (18, 29).
There is also evidence from both the SIV-macaque model of
HIV infection (12) and examination of thymic tissue implanted
into SCID mice (9, 24, 25, 28) for extensive infection of T
lymphocyte precursors in the thymus. Infection of DP cells
during maturation may profoundly reduce the supply of T cells
into the peripheral circulation and cause a marked decline in
circulating numbers of the naive (CD45RA) subsets of CD4
and CD8 lymphocytes during natural infection or in the
SCID-hu mouse animal model (9, 42, 53). Abortive, nonpro-
ductive, or noncytopathic infection of DP cells in the thymus
also leads to the subsequent release of HIV or SIV provirus-
positive CD4 and CD8 lymphocytes into the peripheral circu-
lation (9, 12, 24). Infection during thymic development may
therefore account for the detection of infected naive CD45RA
CD4 lymphocytes in peripheral blood (38), as well as our
recent evidence for measurable frequencies of quiescently in-
fected CD45RA CD8 lymphocytes in the peripheral circula-
tion of a proportion of HIV-seropositive individuals (32). In-
fection of CD4 CD8 lymphocytes found in three individuals
in the present study may similarly represent the outcome of
previous thymic infection.
However, our findings of even more extensive infection of
CD8 lymphocytes after cellular activation indicate an addi-
tional assault on the CD8 lymphocyte population. In particu-
lar, the association of susceptibility and cellular activation ob-
served in in vitro studies suggests that CD8 lymphocytes
recruited to respond to foreign antigen during HIV infection
would be specifically targeted for HIV infection and destruc-
tion. The process of specific deletion of responding CD8 lym-
phocytes would produce a potentially devastating impairment
of cytotoxic T-lymphocyte function, disproportionate to the
decline in circulating CD8 lymphocyte number and potentially
a major contribution to the overall immunosuppression seen in
HIV infection. Destruction of antigen-responding CD8 lym-
phocytes may underlie the previously observed rapid disap-
pearance of HIV-reactive clones of CD8 lymphocytes that oc-
curs during acute infection with HIV but not other viruses (40)
and following adoptive transfer of CD8 lymphocytes into SCID
mice or humans infected with HIV, particularly in the absence
of escape mutations in target epitopes (33).
In the future, it will be important to functionally characterize
HIV isolates infecting different lymphocyte subsets in vivo.
While the bulk of the evidence available to date indicates that
infection of CD8 lymphocytes is restricted to a CD4-dependent
pathway either on activation or in the thymus, apparently CD8-
tropic isolates of HIV-1 that use the CD8 surface molecule as
a receptor have recently been described (44, 54). Indeed, until
CD4 dependence can be demonstrated for naturally occurring
isolates of HIV-1 infecting CD8 lymphocytes, the preferential
distribution of proviral sequences in the DP CD8 lymphocytes
observed in this study might conceivably result simply from the
requirement of HIV for cellular activation for productive in-
fection and therefore be independent of the observed up-
regulation not only of CD4 but of the coreceptor CCR5, which
is apparently also not used for virus entry by these isolates (54).
Whether these apparently CD4-independent viruses are widely
distributed in HIV-1-infected individuals or whether HIV vari-
ants normally use cell surface-expressed CD4 to enter CD8
lymphocytes remains to be determined.
ACKNOWLEDGMENTS
We thank the patients and staff at the Regional Infectious Disease
Unit for providing samples for analysis and Caroline Wilson for pro-
viding clinical information for the study subjects.
Grant support for this study was provided by the Medical Research
Council (G9632414).
REFERENCES
1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M.
Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1 alpha,
MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
Science 272:1955–1958.
2. Bass, H. Z., W. D. Hardy, R. T. Mitsuyasu, Y. X. Wang, W. Cumberland, and
J. L. Fahey. 1992. Eleven lymphoid phenotypic markers in HIV infection:
selective changes induced by zidovudine treatment. J. Acquir. Immune
Defic. Syndr. 5:890–897.
3. Bass, H. Z., P. Nishanian, W. D. Hardy, R. T. Mitsuyasu, E. Esmail, W.
Cumberland, and J. L. Fahey. 1992. Immune changes in HIV-1 infection:
significant correlations and differences in serum markers and lymphoid phe-
notypic antigens. Clin. Immunol Immunopathol. 64:63–70.
4. Benito, J. M., J. M. Zabay, J. Gil, M. Bermejo, A. Escudero, E. Sanchez, and
E. Fernandez-Cruz. 1997. Quantitative alterations of the functionally distinct
subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection:
changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR,
and CD25 antigens. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:
128–135.
5. Bleul, C. C., L. J. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997.
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and
regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925–1930.
6. Bouscarat, F., M. Levacher, R. Landman, M. MuffatJoly, P. M. Girard, A. C.
Saimot, F. Brunvezinet, and M. Sinet. 1998. Changes in blood CD8 lym-
phocyte activation status and plasma HIV RNA levels during antiretroviral
therapy. AIDS 12:1267–1273.
7. Brinchmann, J. E., B. I. Rosok, and A. Spurkland. 1998. Activation and
proliferation of CD8 T cells in lymphoid tissues of HIV-1-infected indi-
viduals in the absence of the high-affinity IL-2 receptor. J. Acquir. Immune
Defic. Syndr. Hum. Retrovirol. 19:332–338.
8. Brod, S. A., M. Purvee, D. Benjamin, and D. A. Hafler. 1990. Frequency anal-
ysis of CD4CD8 T cells cloned with IL-4. Cell. Immunol. 125:426–436.
9. Brooks, D. G., S. G. Kitchen, C. M. Kitchen, D. D. Scripture-Adams, and
J. A. Zack. 2001. Generation of HIV latency during thymopoiesis. Nat. Med.
7:459–464.
10. Chun, T. W., K. Chadwick, J. Margolick, and R. F. Siliciano. 1997. Differ-
ential susceptibility of naive and memory CD4() T cells to the cytopathic
effects of infection with human immunodeficiency virus type 1 strain LAI.
J. Virol. 71:4436–4444.
11. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F.
Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential
component of the receptor for the AIDS retrovirus. Nature 312:763–767.
12. Dean, G. A., G. H. Reubel, and N. C. Pedersen. 1996. Simian immunodefi-
ciency virus infection of CD8 lymphocytes in vivo. J. Virol. 70:5646–5650.
13. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. X. Huang, K. A.
Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A.
Paxton. 1996. HIV-1 entry into CD4() cells is mediated by the chemokine
receptor CC-CKR-5. Nature 381:667–673.
14. Farnet, C. M., and F. D. Bushman. 1997. HIV-1 cDNA integration: require-
ment of HMG I(Y) protein for function of preintegration complexes in vitro.
Cell 88:483–492.
15. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry
cofactor: functional cDNA cloning of a seven-transmembrane, G protein-
coupled receptor. Science 272:872–877.
16. Flamand, L., R. W. Crowley, P. Lusso, S. ColombiniHatch, D. M. Margolis,
and R. C. Gallo. 1998. Activation of CD8() T lymphocytes through the T
cell receptor turns on CD4 gene expression: implications for HIV pathogen-
esis. Proc. Natl. Acad. Sci. USA 95:3111–3116.
17. Giorgi, J. V., H. N. Ho, K. Hirji, C. C. Chou, L. E. Hultin, S. O’Rourke, L.
Park, J. B. Margolick, J. Ferbas, and J. P. Phair. 1994. CD8 lymphocyte
activation at human immunodeficiency virus type 1 seroconversion: devel-
opment of HLA-DR CD38- CD8 cells is associated with subsequent
VOL. 75, 2001 INFECTION OF ACTIVATED CD4 CD8 LYMPHOCYTES BY HIV-1 11563
stable CD4 cell levels. The Multicenter AIDS Cohort Study Group. J. In-
fect. Dis. 170:775–781.
18. Herbein, G., U. Mahlknecht, F. Batliwalla, P. Gregersen, T. Pappas, J.
Butler, W. A. O. Brien, and E. Verdin. 1998. Apoptosis of CD8() T cells is
mediated by macrophages through interaction of HIV gp120 with chemokine
receptor CXCR4. Nature 395:189–194.
19. Ho, H. N., L. E. Hultin, R. T. Mitsuyasu, J. L. Matud, M. A. Hausner, D.
Bockstoce, C. C. Chou, S. O’Rourke, J. M. G. Taylor, and J. V. Giorgi. 1993.
Circulating HIV-specific CD8 cytotoxic T cells express CD38 and
HLA-DR antigens. J. Immunol. 150:3070–3079.
20. Hori, T., X. Paliard, R. de Waal Malefijt, M. Ranes, and H. Spits. 1991.
Comparative analysis of CD8 expressed on mature CD4 CD8 T cell
clones cultured with IL-4 and that on CD8 T cell clones: implication for
functional significance of CD8 beta. Int. Immunol. 3:737–741.
21. Jose, B., S. R. Friedman, A. Neaigus, R. Curtis, J. P. C. Grund, M. F. Gold-
stein, T. P. Ward, and D. C. D. Jarlais. 1993. Syringe-mediated drug-sharing
(backloading)—a new risk factor for HIV among injecting drug users. AIDS 7:
1653–1660.
22. Kalams, S. A., and B. D. Walker. 1998. The critical need for CD4 help in main-
taining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:2199–2204.
23. Kitchen, S. G., Y. D. Korin, M. D. Roth, A. Landay, and J. A. Zack. 1998.
Costimulation of naive CD8 lymphocytes induces CD4 expression and
allows human immunodeficiency virus type 1 infection. J. Virol. 72:9054–9060.
24. Kitchen, S. G., C. H. Uittenbogaart, and J. A. Zack. 1997. Mechanism of
human immunodeficiency virus type 1 localization in CD4-negative thymo-
cytes: differentiation from a CD4-positive precursor allows productive infec-
tion. J. Virol. 71:5713–5722.
25. Kitchen, S. G., and J. A. Zack. 1997. CXCR4 expression during lymphopoi-
esis: implications for human immunodeficiency virus type 1 infection of the
thymus. J. Virol. 71:6928–6934.
26. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Her-
cend, J. C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule
behaves as the receptor for human retrovirus LAV. Nature 312:767–768.
27. LaSalle, J. M., and D. A. Hafler. 1991. The coexpression of CD45RA and
CD45RO isoforms on T cells during the S/G2/M stages of cell cycle. Cell.
Immunol. 138:197–206.
28. Lee, S., H. Goldstein, M. Baseler, J. Adelsberger, and H. Golding. 1997.
Human immunodeficiency virus type 1 infection of mature CD3(hi)CD8()
thymocytes. J. Virol. 71:6671–6676.
29. Lewis, D. E., D. S. N. Tang, A. Aduoppong, W. Schober, and J. R. Rodgers.
1994. Anergy and apoptosis in CD8 T cells from HIV-infected persons.
J. Immunol. 153:412–420.
30. Livingstone, W. J., M. Moore, D. Innes, J. E. Bell, P. Simmonds, J. Whitelaw,
R. Wyld, J. R. Robertson, and R. P. Brettle. 1996. Frequent infection of pe-
ripheral blood CD8-positive T-lymphocytes with HIV-1. Lancet 348:649–654.
31. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss,
and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is
expressed in the immune system and the brain. Cell 47:333–348.
32. McBreen, S., S. Imlach, G. R. Scott, C. Leen, J. E. Bell, and P. Simmonds.
2001. Preferential infection of the CD45RA (naive) subset of CD8 lym-
phocytes by human immunodeficiency virus type 1 in vivo. J. Virol. 75:
4091–4102.
33. McKinney, D. M., D. A. Lewinsohn, S. R. Riddell, P. D. Greenberg, and D. E.
Mosier. 1999. The antiviral activity of HIV-specific CD8() CTL clones is
limited by elimination due to encounter with HIV-infected targets. J. Im-
munol. 163:861–867.
34. Mercure, L., D. Phaneuf, and M. A. Wainberg. 1993. Detection of uninte-
grated human immunodeficiency virus type-1 DNA in persistently infected
CD8 cells. J. Gen. Virol. 74:2077–2083.
35. Mo, H. M., S. Monard, H. Pollack, J. Ip, G. Rochford, L. J. Wu, J. Hoxie, W.
Borkowsky, D. D. Ho, and J. P. Moore. 1998. Expression patterns of the HIV
type 1 coreceptors CCR5 and CXCR4 on CD4() T cells and monocytes
from cord and adult blood. AIDS Res. Hum. Retroviruses 14:607–617.
36. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. C. Meuer. 1991.
Expression of different CD8 isoforms on distinct human lymphocyte sub-
populations. Eur. J. Immunol. 21:1793–1800.
37. Murayama, Y., R. Mukai, M. InoueMurayama, and Y. Yoshikawa. 1999. An
African green monkey lacking peripheral CD4 lymphocytes that retains helper
T cell activity and coexists with SIVagm. Clin. Exp. Immunol. 117:504–512.
38. Ostrowski, M. A., T. W. Chun, S. J. Justement, I. Motola, M. A. Spinelli, J.
Adelsberger, L. A. Ehler, S. B. Mizell, C. W. Hallahan, and A. S. Fauci. 1999.
Both memory and CD45RA/CD62L naive CD4 T cells are infected in
human immunodeficiency virus type 1-infected individuals. J. Virol. 73:6430–
6435.
39. Paliard, X., R. W. Malefijt, J. E. de Vries, and H. Spits. 1988. Interleukin-4
mediates CD8 induction on human CD4 T-cell clones. Nature 335:642–644.
40. Pantaleo, G., H. Soudeyns, J. F. Demarest, M. Vaccarezza, C. Graziosi, S.
Paolucci, M. Daucher, O. J. Cohen, F. Denis, W. E. Biddison, R. P. Sekaly,
and A. S. Fauci. 1997. Evidence for rapid disappearance of initially expanded
HIV-specific CD8() T cell clones during primary HIV infection. Proc. Natl.
Acad. Sci. USA 94:9848–9853.
41. Plaeger, S., H. Z. Bass, P. Nishanian, J. Thomas, N. Aziz, R. Detels, J. King,
W. Cumberland, M. Kemeny, and J. L. Fahey. 1999. The prognostic signif-
icance in HIV infection of immune activation represented by cell surface
antigen and plasma activation marker changes. Clin. Immunol. 90:238–246.
42. Roederer, M., J. G. Dubs, M. T. Anderson, P. A. Raju, and L. A. Herzenberg.
1995. CD8 naive T cell counts decrease progressively in HIV-infected adults.
J. Clin. Invest. 95:2061–2066.
43. Roederer, M., P. A. Raju, D. K. Mitra, and L. A. Herzenberg. 1997. HIV does
not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest.
99:1555–1564.
44. Saha, K., J. Zhang, and B. Zerhouni. 2001. Evidence of productively infected
CD8 T cells in patients with AIDS: implications for HIV-1 pathogenesis.
J. Acquir. Immune Defic. Syndr. 26:199–207.
45. Simmonds, P., P. Balfe, J. F. Peutherer, C. A. Ludlam, J. O. Bishop, and A. J.
Leigh Brown. 1990. Human immunodeficiency virus-infected individuals
contain provirus in small numbers of peripheral mononuclear cells and at
low copy numbers. J. Virol. 64:864–872.
46. Spina, C. A., H. E. Prince, and D. D. Richman. 1997. Preferential replication
of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes
in vitro. J. Clin. Invest. 99:1774–1785.
47. Steffens, C. M., L. Al-Harthi, S. Shott, R. Yogev, and A. Landay. 2000.
Evaluation of thymopoiesis using T cell receptor excision circles (TRECs):
differential correlation between adult and pediatric TRECs and naive phe-
notypes. Clin. Immunol. 97:95–101.
48. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990.
HIV-1 replication is controlled at the level of T cell activation and proviral
integration. EMBO. J. 9:1551–1560.
49. Vanhecke, D., G. Leclercq, J. Plum, and B. Vandekerckhove. 1995. Charac-
terization of distinct stages during the differentiation of human CD69
CD3 thymocytes and identification of thymic emigrants. J. Immunol. 155:
1862–1872.
50. Yang, L. P., J. L. Riley, R. G. Carroll, C. H. June, J. Hoxie, B. K. Patterson,
Y. Ohshima, R. J. Hodes, and G. Delespesse. 1998. Productive infection of
neonatal CD8() T lymphocytes by HIV-1. J. Exp. Med. 187:1139–1144.
51. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen.
1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis
reveals a labile, latent viral structure. Cell 61:213–222.
52. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Y. Chen. 1992. Incompletely
reverse transcribed human immunodeficiency virus type 1 genomes in qui-
escent cells can function as intermediates in the retroviral life cycle. J. Virol.
66:1717–1725.
53. Zaunders, J., A. Carr, L. McNally, R. Penny, and D. A. Cooper. 1995. Effects
of primary HIV-1 infection on subsets of CD4 and CD8 T lymphocytes.
AIDS 9:561–566.
54. Zhang, J., A. Gupta, R. Dave, M. Yimen, B. Zerhouni, and K. Saha. 2001.
Isolation of primary HIV-1 that target CD8 T lymphocytes using CD8 as
a receptor. Nat. Med. 7:65–72.
11564 IMLACH ET AL. J. VIROL.
